Primary Peptides, Inc.
PrivateLast Round
Series A
Feb 1, 2025
Est. Valuation
$75M
Total Funding Raised
$229,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Primary Peptides, Inc. is a biotechnology company that develops novel peptide therapeutics for neurological and cardiovascular diseases using protein manipulation technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Primary Peptides, Inc. Comparables
Compare Primary Peptides, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argenica Therapeutics | 83% | |
| Axoltis Pharma | 82% | |
| Infensa Bioscience | 79% | |
Primary Peptides, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 1, 2025 | ||||
| Grant | May 1, 2023 | ||||
| Grant | May 2, 2022 |
Primary Peptides, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Research Council of Canada | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 413% MoM.
- May 15, 2026
Monthly visitors increased 435% MoM.
Primary Peptides, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Primary Peptides, Inc.'s valuation, stock price, and market status.